A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance

Stanislav Dikiy(Scripps Institution of Oceanography), Yongqiang Feng(St. Jude Children's Research Hospital), Yiping Fan(St. Jude Children's Research Hospital), Alexander Y. Rudensky(Memorial Sloan Kettering Cancer Center), Zhong-Min Wang(Memorial Sloan Kettering Cancer Center), Menglin Jiang(St. Jude Children's Research Hospital), Lu Bai(Queen's University Belfast), Beisi Xu(St. Jude Children's Research Hospital), Laura J. Janke(St. Jude Children's Research Hospital), Jun Li(St. Jude Children's Research Hospital), Xiaolei Hao(St. Jude Children's Research Hospital), Xinying Zong(St. Jude Children's Research Hospital), Beatrice Hoyos(Memorial Sloan Kettering Cancer Center)
Immunity
April 9, 2021
10.1016/j.immuni.2021.03.020
Cited by 100

Related Papers

RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3
|Cell|2014|562
Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway
|The Journal of Experimental Medicine|2010|469
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy
|Nature|2019|445
The genomic landscape of pediatric acute lymphoblastic leukemia
|Nature Genetics|2022|412
NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs
|Cell|2023|407